HTG Molecular Diagnostics (HTGM) Prices 3.57M Common IPO at $14/Share

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a provider of instruments and reagents for molecular profiling applications, today announced the pricing of its initial public offering of 3,570,000 shares of its common stock at an initial public offering price of $14.00 per share. All of the shares of common stock are being offered by HTG. The Company's common stock is expected to begin trading today, May 6, 2015, on the NASDAQ Global Market and under the ticker symbol "HTGM." In addition, HTG has granted the underwriters a 30-day option to purchase up to an additional 535,500 shares of common stock at the offering price. The offering is expected to close on May 11, 2015, subject to customary closing conditions.

Leerink Partners LLC is acting as sole book-running manager for the offering and Canaccord Genuity Inc. and JMP Securities LLC are acting as co-managers for the offering.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on May 5, 2015.

You May Also Be Interested In

• Rubrik IPO: 5 key things to know
• Games Global (GGL) Files for Proposed IPO
• Loar Holdings (LOAR) Announces 11M Share IPO at $24-$26/sh